BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 28861931)

  • 1. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of TRIM25 mediated ubiquitination of metastasis associated protein (MTA) 1 in normal liver cells.
    Li YH; Zhong M; Zang HL; Tian XF
    Exp Cell Res; 2018 Oct; 371(1):250-254. PubMed ID: 30118695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma.
    Li YH; Zhong M; Zang HL; Tian XF
    Exp Cell Res; 2018 Jul; 368(1):37-41. PubMed ID: 29654742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
    Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
    Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.
    Bian W; Zhang H; Tang M; Zhang S; Wang L; Liu L; Wang W
    Cell Physiol Biochem; 2018; 51(5):2065-2072. PubMed ID: 30522116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis.
    Deng L; Yang H; Tang J; Lin Z; Yin A; Gao Y; Wang X; Jiang R; Sun B
    J Exp Clin Cancer Res; 2015 Oct; 34():128. PubMed ID: 26503703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
    Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
    Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
    IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
    Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
    Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
    Zhao L; Zhang P; Su XJ; Zhang B
    J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Zhang CZ
    J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis.
    Nasrullah U; Haeussler K; Biyanee A; Wittig I; Pfeilschifter J; Eberhardt W
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.
    Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J
    BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells.
    Yoo YG; Na TY; Seo HW; Seong JK; Park CK; Shin YK; Lee MO
    Oncogene; 2008 May; 27(24):3405-13. PubMed ID: 18264140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
    Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
    Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ.
    Lee JM; Choi SS; Lee YH; Khim KW; Yoon S; Kim BG; Nam D; Suh PG; Myung K; Choi JH
    Exp Mol Med; 2018 Oct; 50(10):1-11. PubMed ID: 30323259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.
    Wong D; Sogerer L; Lee SS; Wong V; Lum A; Levine AB; Marra MA; Yip S
    BMC Biol; 2020 Oct; 18(1):154. PubMed ID: 33115448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.